Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLombard Risk Management Regulatory News (LRM)

  • There is currently no data for LRM

Regulatory Contracts Won

13 Jan 2010 07:00

RNS Number : 4374F
Lombard Risk Management PLC
13 January 2010
 



LOMBARD RISK MANAGEMENT WINS SIX REGULATORY CONTRACTS IN UK

London, 13th January 2010

Lombard Risk Management plc, ("Lombard Risk" or the "Company") the global provider of specialised software solutions that improve the management of collateralised trading, liquidity and regulatory compliance, has won its first regulatory contract of 2010. This takes to six the total of contracts won by Lombard Risk for UK regulatory reporting in the last two months. These six contracts have a total first year value of over £500,000. Some of the revenue from these contracts will be recognized in the current financial year, but owing to the Company's revenue recognition policy the majority will be recognized in the financial year to March 2011. One of these six firms is a new client, and the others are existing bank and building society clients of Lombard Risk for regulatory reporting who are expanding the scope of their contracts to include the new Liquidity Standards finalized by the FSA in October 2009. Four of these clients' contracts include signing up at the same time for Lombard Risk's liquidity stress testing software.

John Wisbey, CEO of Lombard Risk commented

"We are very pleased to have won the business of another new client in the UK and the further business of a number of UK banks and building societies that already use us for their FSA regulatory reporting in the UK in which we are the market leader. We have many more customers who will be making decisions shortly, and we believe they will take great comfort from the fact that our software delivery is on track and that we have closely integrated solutions both for the liquidity regulatory reporting element and for the associated liquidity stress testing and scenario analysis. The latter, which is going to be required by the FSA and other international regulators, is in any case prudent liquidity risk management and therefore helps with good management of a bank as well as in complying with regulations."

 "In a world of increasing financial regulation, some of the world's top banks rely on Lombard Risk to report to regulators and to monitor and manage their risk. Our products in Collateral Management, Liquidity and Regulatory Compliance are all increasingly complementary as banks and regulators alike look in ever more similar ways at counterparty risk, liquidity and collateral flows". 

"The Company is at an exciting position in its development. Following the capital raising in October 2009, our platform for growth is excellent. We are investing in accelerating the growth of the business. We are confident that we will be able to update shareholders on further new contract wins shortly."

Note to Editors 

The FSA's Liquidity Standards initiative as outlined in the FSA's policy statement PS 09/16* affects all banks in the UK. Other than those banks able to obtain a modification or waiver from the FSA, which means many foreign bank branches in the UK, all UK banks and building societies and many investment firms will need to spend money on complying with the new Liquidity Standards regulations. PS09/16 can be found on http://www.fsa.gov.uk/pages/Library/Policy/Policy/2009/09_16.shtml

-ends-

For further information please contact:

Lombard Risk Management plc 

John Wisbey, Chairman and Chief Executive 

Keith Butcher, Finance Director

Tel: 020-7089-3700 

Noble & Company Limited 

John Llewellyn-Lloyd

Sam Reynolds

Tel: 020-7763-2200

City Profile 

Simon Courtenay

Tel: 020-7448-3244

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTLLFVRLVIFLII
Date   Source Headline
18th Feb 20161:21 pmRNSHolding(s) in Company
12th Feb 20164:24 pmRNSHolding(s) in Company
5th Feb 20167:00 amRNSNew Global Head of Product
25th Jan 201610:31 amRNSBoard Change
15th Jan 20167:00 amRNSExercise of Options
11th Jan 20167:00 amRNSExercise of Options
6th Jan 20167:00 amRNSExercise of Options
29th Dec 201510:44 amRNSExercise of Options
18th Dec 20157:00 amRNSHolding(s) in Company
16th Dec 20157:00 amRNSExercise of share options
1st Dec 20153:09 pmRNSGrant of Share Options
27th Nov 20157:00 amRNSAppointment of CEO
25th Nov 20157:00 amRNSDirector/PDMR Shareholding
5th Nov 20157:00 amRNSUS and Canadian Client Successes
4th Nov 201511:17 amRNSDirector/PDMR Shareholding
3rd Nov 20155:06 pmRNSHolding(s) in Company
29th Oct 20157:00 amRNSIssue of Equity
27th Oct 20157:00 amRNSDirector/PDMR Shareholding
26th Oct 20155:12 pmRNSLombard Risk co-present at Oracle OpenWorld
22nd Oct 20157:00 amRNSChange of Adviser
22nd Oct 20157:00 amRNSHalf Yearly Report
8th Oct 20157:00 amRNSNotice of Results
9th Sep 201512:15 pmRNSReplacement - Board Changes
9th Sep 20158:45 amRNSBoard Changes
9th Sep 20157:00 amRNSIssue of Equity
8th Sep 20157:00 amRNSBoard Changes
18th Aug 201512:21 pmRNSBoard changes
5th Aug 20152:52 pmRNSExercise of Options
5th Aug 201512:37 pmRNSSenior Management Appointment
30th Jul 20152:42 pmRNSDirector/PDMR Shareholding
9th Jul 201512:34 pmRNSResult of AGM
9th Jul 20157:00 amRNSAGM Statement
30th Jun 20154:29 pmRNSTotal Voting Rights
12th Jun 20157:00 amRNSSumitomo Mitsui Trust Bank London goes live
4th Jun 20153:23 pmRNSHolding(s) in Company
3rd Jun 201510:47 amRNSHolding(s) in Company
1st Jun 20153:38 pmRNSTotal Voting Rights
28th May 20157:00 amRNSBoard Changes
28th May 20157:00 amRNSExercise of Options
26th May 20153:30 pmRNSIssue of Equity
21st May 20157:00 amRNSBoard Changes
21st May 20157:00 amRNSFinal Results
19th May 20157:00 amRNSDirectorate Change
7th May 20157:00 amRNSNotice of Results
23rd Apr 201512:30 pmRNSContract Wins
11th Mar 201511:00 amRNSTrading Update
20th Feb 20157:00 amRNSChange of Registered Office
2nd Feb 20155:20 pmRNSExercise of Options
19th Jan 20154:45 pmRNSExercise of options
31st Dec 20147:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.